Does early-life exposure to organophosphate insecticides lead to prediabetes and obesity?

Reproductive Toxicology

Volumn 31, Issue 3, 2011, Pages 297-301

  Slotkin, Theodore A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase signaling; Chlorpyrifos; Cyclic AMP; Diabetes; Diazinon; Dietary fat; Liver; Neurodevelopmental disorders; Obesity; Organophosphate pesticides; Parathion

Indexed keywords

ADENYLATE CYCLASE; CHLORPYRIFOS; CHOLINESTERASE; CYCLIC AMP; DIMPYLATE; ORGANOPHOSPHATE INSECTICIDE; PARATHION;

ADVERSE OUTCOME; CHOLINESTERASE INHIBITION; EARLY LIFE STRESS; GLUCONEOGENESIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KETOGENIC DIET; LIPID DIET; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; TOXICITY TESTING; WEIGHT GAIN;

ADENYLATE CYCLASE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CYCLIC AMP; DIETARY FATS; ENVIRONMENTAL EXPOSURE; FEEDING BEHAVIOR; FEMALE; HUMANS; INSECTICIDES; LIVER; OBESITY; PHOSPHORIC ACID ESTERS; PREDIABETIC STATE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

ANIMALIA; RATTUS;

EID: 79953765443     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.07.012     Document Type: Review

References (70)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Onkamo P., Vaananen S., Karvonen M., Tuomilehto J. Worldwide increase in incidence of type I diabetes-the analysis of the data on published incidence trends. Diabetologia 1999, 42:1395-1403.
3. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
4. Stein C.J., Colditz G.A. The epidemic of obesity. J Clin Endocrinol Metab 2004, 89:2522-2525.
5. Wang Y., Beydoun M.A. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
6. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
7. Al Mamun A., Lawlor D.A., Alati R., O'Callaghan M.J., Williams G.M., Najman J.M. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol 2006, 164:317-325.
8. Chen A., Pennell M.L., Klebanoff M.A., Rogan W.J., Longnecker M.P. Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Intl J Epidemiol 2006, 35:121-130.
9. Gao Y.J., Holloway A.C., Zeng Z.H., Lim G.E., Petrik J.J., Foster W.G., et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obesity Res 2005, 13:687-692.
10. Power C., Jefferis B.J. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol 2002, 31:413-419.
11. Toschke A.M., Ehlin A.G., von Kries R., Ekbom A., Montgomery S.M. Maternal smoking during pregnancy and appetite control in offspring. J Perinatal Med 2003, 31:251-256.
12. von Kries R., Toschke A.M., Koletzko B., Slikker W. Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol 2002, 156:954-961.
13. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 2004, 17:983-998.
14. Morgan M.K., Sheldon L.S., Croghan C.W., Jones P.A., Robertson G.L., Chuang J.C., et al. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments. J Exposure Anal Environ Epidemiol 2005, 15:297-309.
15. Morgan D.P., Lin L.I., Saikaly H.H. Morbidity and mortality in workers occupationally exposed to pesticides. Arch Environ Contam Toxicol 1980, 9:349-382.
16. Saldana T.M., Basso O., Hoppin J.A., Baird D.D., Knott C., Blair A., et al. Pesticide exposure and self-reported gestational diabetes mellitus in the Agricultural Health Study. Diabetes Care 2007, 30:529-534.
17. Curl C.L., Fenske R.A., Kissel J.C., Shirai J.H., Moate T.F., Griffith W., et al. Evaluation of take-home organophosphorus pesticide exposure among agricultural workers and their children. Environ Health Perspect 2002, 110:A787-A792.
18. Fenske R.A., Kissel J.C., Lu C., Kalman D.A., Simcox N.J., Allen E.H., et al. Biological based pesticide dose estimates for children in an agricultural community. Environ Health Perspect 2000, 108:515-520.
19. Petchuay C., Visuthismajarn P., Vitayavirasak B., Hore P., Robson M.G. Biological monitoring of organophosphate pesticides in preschool children in an agricultural community in Thailand. Intl J Occup Environ Health 2006, 12:134-141.
20. Rothlein J., Rohlman D., Lasarev M., Phillips J., Muniz J., McCauley L. Organophosphate pesticide exposure and neurobehavioral performance in agricultural and nonagricultural Hispanic workers. Environ Health Perspect 2006, 114:691-696.
21. Perera F.P., Rauh V., Whyatt R.M., Tang D., Tsai W.Y., Bernert J.T., et al. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology 2005, 26:573-587.
22. Whyatt R.M., Camann D., Perera F.P., Rauh V.A., Tang D., Kinney P.L., et al. Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol 2005, 206:246-254.
23. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 2007, 115:792-798.
24. Whyatt R.M., Garfinkel R., Hoepner L.A., Holmes D., Borjas M., Williams M.K., et al. Within- and between-home variability in indoor-air insecticide levels during pregnancy among an inner-city cohort from New York City. Environ Health Perspect 2007, 115:383-389.
25. Garry V.F. Pesticides and children. Toxicol Appl Pharmacol 2004, 198:152-163.
26. Landrigan P.J., Claudio L., Markowitz S.B., Berkowitz G.S., Brenner B.L., Romero H., et al. Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect 1999, 107(suppl 3):431-437.
27. National Research Council Pesticides in the diets of infants and children 1993, National Academy Press, Washington, DC.
28. Physicians for Social Responsibility Pesticides and Children 1995, Physicians for Social Responsibility, Washington, DC.
29. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 2004, 198:132-151.
30. Slotkin T.A. Developmental neurotoxicity of organophosphates: a case study of chlorpyrifos. Toxicity of organophosphate and carbamate pesticides 2005, 293-314. Elsevier Academic Press, San Diego. R.C. Gupta (Ed.).
31. Meyer A., Seidler F.J., Aldridge J.E., Tate C.A., Cousins M.M., Slotkin T.A. Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure. Environ Health Perspect 2004, 112:295-301.
32. Meyer A., Seidler F.J., Slotkin T.A. Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ Health Perspect 2004, 112:170-178.
33. Meyer A., Seidler F.J., Cousins M.M., Slotkin T.A. Developmental neurotoxicity elicited by gestational exposure to chlorpyrifos: when is adenylyl cyclase a target?. Environ Health Perspect 2003, 111:1871-1876.
34. Zhang H.S., Liu J., Pope C.N. Age-related effects of chlorpyrifos on muscarinic receptor-mediated signaling in rat cortex. Arch Toxicol 2002, 75:676-684.
35. Olivier K., Liu J., Pope C. Inhibition of forskolin-stimulated cAMP formation in vitro by paraoxon and chlorpyrifos oxon in cortical slices from neonatal, juvenile, and adult rats. J Biochem Mol Toxicol 2001, 15:263-269.
36. Ward T.R., Mundy W.R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res Bull 1996, 39:49-55.
37. Adigun A.A., Ryde I.T., Seidler F.J., Slotkin T.A. Organophosphate exposure during a critical developmental stage reprograms adenylyl cyclase signaling in PC12 cells. Brain Res 2010, 1329:36-44.
38. Adigun A.A., Seidler F.J., Slotkin T.A. Disparate developmental neurotoxicants converge on the cyclic AMP signaling cascade, revealed by transcriptional profiles in vitro and in vivo. Brain Res 2010, 1316:1-16.
39. Adigun A.A., Wrench N., Seidler F.J., Slotkin T.A. Neonatal organophosphorus pesticide exposure alters the developmental trajectory of cell signaling cascades controlling metabolism: differential effects of diazinon and parathion. Environ Health Perspect 2010, 118:210-215.
40. Adigun A.A., Wrench N., Seidler F.J., Slotkin T.A. Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood. Neurotoxicol Teratol 2010, 32:193-199.
41. Meggs W.J., Brewer K.L. Weight gain associated with chronic exposure to chlorpyrifos in rats. J Med Toxicol 2007, 3:89-93.
42. Abdollahi M., Donyavi M., Pournourmohammadi S., Saadat M. Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion. Comp Biochem Physiol Toxicol Pharmacol 2004, 137:343-347.
43. Lassiter T.L., Brimijoin S. Rats gain excess weight after developmental exposure to the organophosphorothionate pesticide, chlorpyrifos. Neurotoxicol Teratol 2008, 30:125-130.
44. Slotkin T.A., Brown K.K., Seidler F.J. Developmental exposure of rats to chlorpyrifos elicits sex-selective hyperlipidemia and hyperinsulinemia in adulthood. Environ Health Perspect 2005, 113:1291-1294.
45. Adigun A.A., Wrench N., Levin E.D., Seidler F.J., Slotkin T.A. Neonatal parathion exposure and interactions with a high-fat diet in adulthood: adenylyl cyclase-mediated cell signaling in heart, liver and cerebellum. Brain Res Bull 2010, 81:605-612.
46. Lassiter T.L., Ryde I.T., Levin E.D., Seidler F.J., Slotkin T.A. Neonatal exposure to parathion alters lipid metabolism in adulthood: interactions with dietary fat intake and implications for neurodevelopmental deficits. Brain Res Bull 2010, 81:85-91.
47. Lassiter T.L., Ryde I.T., MacKillop E.A., Brown K.K., Levin E.D., Seidler F.J., et al. Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ Health Perspect 2008, 116:1456-1462.
48. Roegge C.S., Timofeeva O.A., Seidler F.J., Slotkin T.A., Levin E.D. Developmental diazinon neurotoxicity in rats: later effects on emotional response. Brain Res Bull 2008, 75:166-172.
49. Slotkin T.A., Lassiter T.L., Ryde I.T., Wrench N., Levin E.D., Seidler F.J. Consumption of a high-fat diet in adulthood ameliorates the effects of neonatal parathion exposure on acetylcholine systems in rat brain regions. Environ Health Perspect 2009, 117:916-922.
50. Bough K.J., Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
51. Connolly M.B., Hendson G., Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nervous System 2006, 22:896-908.
52. Hallbook T., Lundgren J., Rosen I. Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia 2007, 48:59-65.
53. Hartman A.L., Vining E.P.G. Clinical aspects of the ketogenic diet. Epilepsia 2007, 48:31-42.
54. Evangeliou A., Vlachonikolis I., Mihailidou H., Spilioti M., Skarpalezou A., Makaronas N., et al. Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol 2003, 18:113-118.
55. Pulsifer M.B., Gordon J.M., Brandt J., Vining E.P., Freeman J.M. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol 2001, 43:301-306.
56. Murphy P., Burnham W.M. The ketogenic diet causes a reversible decrease in activity level in Long-Evans rats. Exp Neurol 2006, 201:84-89.
57. Murphy P., Likhodii S.S., Hatamian M., McIntyre Burnham W. Effect of the ketogenic diet on the activity level of Wistar rats. Pediatr Res 2005, 57:353-357.
58. Teegarden S.L., Nestler E.J., Bale T.L. DeltaFosB-mediated alterations in dopamine signaling are normalized by a palatable high-fat diet. Biol Psychiat 2008, 64:941-950.
59. Gudbjarnason S., Benediktsdottir V.E. Regulation of β-adrenoceptor properties and the lipid milieu in heart muscle membranes during stress. Mol Cell Biochem 1996, 164:137-143.
60. Ponsard B., Durot I., Delerive P., Oudot F., Cordelet C., Grynberg A., et al. Cross-influence of membrane polyunsaturated fatty acids and hypoxia-reoxygenation on α- and β-adrenergic function of rat cardiomyocytes. Lipids 1999, 34:457-466.
61. Clandinin M.T., Foot M., Robson L. Plasma membrane: can its structure and function be modulated by dietary fat?. Comp Biochem Physiol B 1983, 76:335-339.
62. Geiser F. Influence of polyunsaturated and saturated dietary lipids on adipose tissue, brain and mitochondrial membrane fatty acid composition of a mammalian hibernator. Biochim Biophys Acta 1990, 1046:159-166.
63. Kelly J.F., Joseph J.A., Denisova N.A., Erat S., Mason R.P., Roth G.S. Dissociation of striatal GTPase and dopamine release responses to muscarinic cholinergic agonists in F344 rats: influence of age and dietary manipulation. J Neurochem 1995, 64:2755-2764.
64. Deas D., Brown E.S., Deas D., Brown E.S. Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiat 2006, 67:e02.
65. Pliszka S.R., Pliszka S.R. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs 2003, 5:741-750.
66. Wilens T.E., Wilens T.E. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiat Clinics N Am 2004, 27:283-301.
67. Kandel D.B., Wu P., Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Public Health 1994, 84:1407-1413.
68. Weissman M.M., Warner V., Wickramaratne P.J., Kandel D.B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiat 1999, 38:892-899.
69. Jacobsen L.K., Slotkin T.A., Mencl W.E., Frost S.J., Pugh K.R. Gender specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology 2007, 32:2453-2464.
70. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.